Navigation Links
Study finds patients overestimate cancer screening history
Date:4/18/2008

A new American Cancer Society study finds female African American patients tend to overestimate their level of cancer screening, indicating that current estimates of screening based on self-reported data may be lower than reported.

Researchers from the Societys Behavioral Research Center, led by Barbara D. Powe, PhD, RN, interviewed 116 African American female patients at a federally qualified health center (FQHC) and compared their recollection to the screening history documented in the patients medical records for four medical tests: clinical breast examination; mammography; Pap testing; and screening with a fecal occult blood test (FOBT). They found the level of incongruence between self-report and medical record documentation was more than 50 percent for some procedures.

Eighty-six percent of the women who were age 20 or older (n = 94) reported having a CBE in their lifetime, 67 percent in the past year, 20 percent in the past two to five years, and 10 percent more than five years ago. Based on medical record documentation, 35 percent of the women had a CBE in their lifetime, 26 percent in the past year, 4 percent in the past two to five years, and 2 percent more than five years ago.

Seventy-seven percent of the women over 40 (n=35) reported ever having a mammogram in their lifetime, 29 percent in the past year, 29 percent in the past two to five years, and 6 percent more than five years ago. Based on documentation in the medical record, 40 percent of the women had a mammogram in their lifetime, 9 percent in the past year, 26 percent in the past two to five years, and 6 percent more than five years ago.

Of the 43 women asked about Pap test use, 96 percent reported having had a Pap test in their lifetime, 72 percent in the past year, 26 percent in the past two to five years, and 12 percent more than five years ago. Based on documentation in the medical record, 58 percent of the women had a Pap test in their lifetime, 39 percent in the past year, 25 percent in the past two to five years, and 13 percent more than five years ago.

Fifty-six percent of the women over 50 (n=16) reported ever having a fecal occult blood test (FOBT) in their lifetime, 35 percent in the past year, 12 percent in the past two to five years, and 6 percent more than five years ago. Based on documentation in the medical record, 11 percent of the women had a FOBT in their lifetime, 12 percent in the past year, and 0 percent in the past two to five years or more than five years ago.

The researchers acknowledge that the women could have received services without documentation in the medical record or that the women could have mistakenly believed a clinical service included screening when it did not. Nevertheless, they cite previous research that also has found patients tend to over-report their level of screening.

The authors say maintaining efforts to effectively monitor and track participation in cancer screening among African Americans and other groups should be a priority, offering the electronic medical record as one way to ensure more accurate medical documentation. Self-reported screening rates are the foundation for many policy decisions that have a significant influence on the availability of resources for this population, said Dr. Powe. Indeed, over- or underestimation of screening can be even more significant for African Americans, who bear a disproportionate cancer burden.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Parents stricter with older kids to set example: game theory study
2. Study finds 1 in 5 Iraq and Afghanistan veterans suffer from PTSD or major depression
3. RIT study: Sign language interpreters at high ergonomic risk
4. U-M study: Work hassles hamper sleep
5. Study provides new understanding of forces behind seasonal flu virus evolution
6. Seasonal Flu Outbreaks Start in Asia: Study
7. Study examines the effect of epilepsy on the aging
8. Study shows pine bark naturally reduces osteoarthritis
9. Study Shows Pine Bark Naturally Reduces Osteoarthritis
10. Study suggests too much screen time and not enough physical activity may lead to childhood obesity
11. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: